(Q31043317)

28 June 2017

1 reference

title

Role of mucosal ablative therapy in the treatment of the columnar-lined esophagus (English)

1 reference

28 June 2017

Rodney J Pacifico

1

1 reference

28 June 2017

Kenneth K Wang

series ordinal

2

1 reference

28 June 2017

publication date

1 February 2002

1 reference

Chest surgery clinics of North America

28 June 2017

published in

1 reference

28 June 2017

volume

12

1 reference

28 June 2017

issue

1

1 reference

28 June 2017

page(s)

185-203

1 reference

Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

High-grade dysplasia in the columnar-lined esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Barrett's oesophagus: effect of antireflux surgery on symptom control and development of complications

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Distribution of cytokeratin markers in Barrett's specialized columnar epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Repeat laser therapy of recurrent Barrett's epithelium: Success with anacidity

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Laser-induced transient regression of Barrett's epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Gastric acid hypersecretion in refractory gastroesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Treatment of Barrett's esophagus with H2 blockers

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

A new physiologic approach for the surgical treatment of patients with Barrett's esophagus: technical considerations and results in 65 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Surgical therapy in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Treatment of Barrett's esophagus by endoscopic argon plasma coagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Unresolved issues in Barrett's esophagus in the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Argon plasma coagulation (APC): ballyhoo or breakthrough?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Barrett's esophagus: development of dysplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Barrett's ulcer and treatment with cimetidine

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Local treatment of early cancer in short Barrett's esophagus by means of argon plasma coagulation: initial experience

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Barrett's esophagus: update on screening, surveillance, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopic argon plasma coagulation: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Long term continuous omeprazole treatment of patients with Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Photodynamic therapy in the management of Barrett's esophagus with dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Barrett's esophagus with high-grade dysplasia: An indication for esophagectomy?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Regression and progression of Barrett's oesophagus after antireflux surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Lack of impact of therapy on extent of Barrett's esophagus in 67 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Regression of Barrett's esophagus by laser ablation in an anacid environment

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Current status of photodynamic therapy of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Photodynamic therapy of Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Effect of long-term treatment with cimetidine and antacids in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

Effect of antireflux operation on Barrett's mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900073-5

7 January 2021

10.1016/S1052-3359(03)00073-5

Identifiers

DOI

1 reference

28 June 2017

1 reference